UNICHEM LABORATORIES
Back to Income Statement
|
UNICHEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,111 Cr | ₹1,785 Cr | ₹134,302 Cr | ₹1,270 Cr | ₹1,235 Cr |
What is the latest Revenue of UNICHEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,111 Cr |
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹134,302 Cr |
| Mar2023 | ₹1,270 Cr |
| Mar2022 | ₹1,235 Cr |
How is Revenue of UNICHEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,111 Cr | 18.25 | |
| Mar2025 | ₹1,785 Cr | -98.67 | |
| Mar2024 | ₹134,302 Cr | 10,476.38 | |
| Mar2023 | ₹1,270 Cr | 2.81 | |
| Mar2022 | ₹1,235 Cr | - | |
Compare Revenue of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,474.9 Cr | 2.1% | -9.8% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 2.1% |
-9.8% |
6.2% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses